Chronic Myeloproliferative Disorders Withdrawn Phase 1 / 2 Trials for Cyclosporine (DB00091)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00816413Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological CancerTreatment